In conclusion, this study is the first to demonstrate that LeY antigen, as an important component in TβRI and TβRII, participates the development of ovarian cancer by regulating TGF-β1-dependent Smad, ERK and PI3K pathways. The gene discussed is TGFBR2; the disease is ovarian carcinoma.